Related Experiment Videos
Hyperargininemia due to liver arginase deficiency
Eric A Crombez1, Stephen D Cederbaum
1Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Molecular Genetics and Metabolism
|February 8, 2005
Summary
Arginase deficiency, a urea cycle disorder, causes progressive neurological symptoms in children. Early diagnosis and treatment, including diet and medication, can halt disease progression and improve outcomes.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- The urea cycle detoxifies nitrogenous waste, with arginase as the final enzyme.
- Arginase deficiency (hyperargininemia) is an autosomal recessive disorder.
- Two arginase genes (AI and AII) exist, but deficiency primarily involves AI.
Purpose of the Study:
- To summarize the clinical presentation, biochemical, enzymatic, and molecular aspects of arginase deficiency.
- To discuss treatment strategies and prenatal diagnostic options.
- To present the spectrum of arginase deficiency presentations.
Main Methods:
- Clinical case reviews of patients with arginase deficiency.
- Biochemical, enzymatic, and molecular analyses.
- Review of treatment regimens and prenatal diagnosis.
Main Results:
- Arginase deficiency presents uniquely, typically in children aged 2-4 years with neurological symptoms.
- Untreated, the condition leads to progressive developmental milestone loss.
- Dietary and drug management can prevent further deterioration and allow for improvement.
Conclusions:
- Arginase deficiency has a distinct clinical course compared to other urea cycle disorders.
- Prompt diagnosis and consistent treatment are crucial for favorable outcomes.
- Prenatal diagnosis is available for families at risk.